---
figid: PMC3079023__nihms268047f1
figtitle: 'CXCL12 (SDF1A) – CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer
  for Anti-Cancer Therapies?'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3079023
filename: nihms268047f1.jpg
figlink: /pmc/articles/PMC3079023/figure/F1/
number: F1
caption: CXCL12 binds to CXCR4 and CXCR7, which are G protein-coupled receptors (GPCR)
  that can form homodimers or heterodimers. In the latter case, CXCR7 changes the
  conformation of the CXCR4/G-protein complexes and abrogates signaling. Activation
  of CXCR4 by CXCL12 leads to G-protein coupled signaling through PI3K/Akt, IP3, and
  MAPK pathways, which promote cell survival, proliferation and chemotaxis. In addition,
  the β-arrestin pathway can be activated through GRK to internalize CXCR4. When CXCR7
  binds CXCL12, the classical GPCR mobilization of Ca2+ does not occur, and activation
  of the β-arrestin pathway may lead to scavenging of CXCL12. In certain cancer cells
  (e.g., glioma) CXCR7 can also signal through PLC/MAPK to increase cell survival.
papertitle: 'CXCL12 (SDF1α) – CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer
  for Anti-Cancer Therapies?.'
reftext: Dan G. Duda, et al. Clin Cancer Res. ;17(8):2074-2080.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9074677
figid_alias: PMC3079023__F1
figtype: Figure
redirect_from: /figures/PMC3079023__F1
ndex: 6e269582-df0e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3079023__nihms268047f1.html
  '@type': Dataset
  description: CXCL12 binds to CXCR4 and CXCR7, which are G protein-coupled receptors
    (GPCR) that can form homodimers or heterodimers. In the latter case, CXCR7 changes
    the conformation of the CXCR4/G-protein complexes and abrogates signaling. Activation
    of CXCR4 by CXCL12 leads to G-protein coupled signaling through PI3K/Akt, IP3,
    and MAPK pathways, which promote cell survival, proliferation and chemotaxis.
    In addition, the β-arrestin pathway can be activated through GRK to internalize
    CXCR4. When CXCR7 binds CXCL12, the classical GPCR mobilization of Ca2+ does not
    occur, and activation of the β-arrestin pathway may lead to scavenging of CXCL12.
    In certain cancer cells (e.g., glioma) CXCR7 can also signal through PLC/MAPK
    to increase cell survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - norpA
  - sl
  - Plc21C
  - grk
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Arr2
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - MKP-4
  - p38b
  - rl
  - Akt
  - CXCR4
  - ACKR3
  - CXCL12
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - GRK1
  - GRK4
  - GRK5
  - GRK6
  - GRK7
  - GRK2
  - GRK3
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - TRIB3
  - Cancer
---
